8RKQ image
Deposition Date 2023-12-28
Release Date 2024-05-08
Last Version Date 2024-05-08
Entry Detail
PDB ID:
8RKQ
Keywords:
Title:
Structure of human DELTA-1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE (ALDH4A1) complexed with the molecular tweezer CLR01
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 65
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial
Gene (Uniprot):ALDH4A1
Chain IDs:A, B, C, D
Chain Length:567
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
How Do Molecular Tweezers Bind to Proteins? Lessons from X-ray Crystallography.
Molecules 29 ? ? (2024)
PMID: 38675584 DOI: 10.3390/molecules29081764

Abstact

To understand the biological relevance and mode of action of artificial protein ligands, crystal structures with their protein targets are essential. Here, we describe and investigate all known crystal structures that contain a so-called "molecular tweezer" or one of its derivatives with an attached natural ligand on the respective target protein. The aromatic ring system of these compounds is able to include lysine and arginine side chains, supported by one or two phosphate groups that are attached to the half-moon-shaped molecule. Due to their marked preference for basic amino acids and the fully reversible binding mode, molecular tweezers are able to counteract pathologic protein aggregation and are currently being developed as disease-modifying therapies against neurodegenerative diseases such as Alzheimer's and Parkinson's disease. We analyzed the corresponding crystal structures with 14-3-3 proteins in complex with mono- and diphosphate tweezers. Furthermore, we solved crystal structures of two different tweezer variants in complex with the enzyme Δ1-Pyrroline-5-carboxyl-dehydrogenase (P5CDH) and found that the tweezers are bound to a lysine and methionine side chain, respectively. The different binding modes and their implications for affinity and specificity are discussed, as well as the general problems in crystallizing protein complexes with artificial ligands.

Legend

Protein

Chemical

Disease

Primary Citation of related structures